<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00199550</url>
  </required_header>
  <id_info>
    <org_study_id>R-04-533</org_study_id>
    <nct_id>NCT00199550</nct_id>
  </id_info>
  <brief_title>Bipolar vs Monopolar Transurethral Resection of the Prostate (TURP)</brief_title>
  <official_title>A Prospective Randomized Clinical Trial of Bipolar vs Monopolar Transurethral Resection of the Prostate (TURP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lawson Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>GyrusACMI</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Lawson Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will prospectively evaluate a new electrosurgical procedure (bipolar transurethral
      prostatectomy) in men with symptomatic benign prostatic hyperplasia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to demonstrate that the Bipolar TURP using the Vista Controlled
      Tissue Resection System is safe and efficacious as a surgical treatment for men with
      symptomatic BPH, allowing a reduction in the post-operative hospitalization. It is expected
      that bipolar TURP will be safe and efficacious for the surgical treatment of BPH and will
      allow a &lt; 24 hour post-operative hospital stay in &gt; 50% of patients undergoing this
      procedure.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2004</start_date>
  <completion_date type="Actual">June 2008</completion_date>
  <primary_completion_date type="Actual">March 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of efficacy will be determined by comparing pre and post-operative symptom scores.</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pre and post-operative objective and subjective data for each treatment group will be assessed to determine safety and efficacy. Complications related to the surgical procedure will be noted by flexible cystoscopy at 6 months.</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">43</enrollment>
  <condition>BPH</condition>
  <condition>Benign Prostatic Hyperplasia</condition>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bipolar Electrosurgical Unit</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Monopolar Electrosurgical Unit</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bipolar Transurethral Resection of the Prostate</intervention_name>
    <description>Bipolar TURP</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Vista, Bipolar TURP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Monopolar Transurethral Resection of the Prostate</intervention_name>
    <description>Monopolar TURP</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Monopolar TURP</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Symptomatic benign prostatic hyperplasia including patients with acute urinary
             retention;

          -  Peak urinary flow rate &lt; 12 ml/sec;

          -  American Urological Association (AUA) symptom score &gt; 12.

        Exclusion Criteria:

          -  Previous open or transurethral prostatic surgery;

          -  History of urethral stricture;

          -  Failure to discontinue alpha-adrenergic blocking agents for at least 14 days prior to
             surgery;

          -  Failure to discontinue 5-alpha reductase inhibitor for at least 1 month prior to
             surgery;

          -  Patient interested in future fertility;

          -  Patient with known neurogenic bladder dysfunction;

          -  Untreated urinary tract infection;

          -  American Society of Anesthesiologist (ASA) Class &gt;III;

          -  Patients requiring anticoagulation with Coumadin or Heparin;

          -  Patient unable or unwilling to comply with follow-up schedule.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hassan Razvi, MD, FRCSC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Urology, St. Joseph's Hospital, University of Western Ontario</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alberta Urology Institute Research Centre</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T5H 4B9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prostate Centre at Vancouver General Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z 3J5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Can-Med Clinical Research Inc</name>
      <address>
        <city>Victoria</city>
        <state>British Columbia</state>
        <zip>V8R 6T9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hamilton District Urology Associaton</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 1T8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre for Advanced Urological Research at Queen's University</name>
      <address>
        <city>Kingston</city>
        <state>Ontario</state>
        <zip>K7L 3J7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Urology Clinic &amp; Prostate Centre, St. Joseph's Hospital, St. Joseph's Health Care London</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 4V2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2005</study_first_posted>
  <last_update_submitted>July 25, 2008</last_update_submitted>
  <last_update_submitted_qc>July 25, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 29, 2008</last_update_posted>
  <responsible_party>
    <name_title>Dr. Hassan Razvi</name_title>
    <organization>The University of Western Ontario</organization>
  </responsible_party>
  <keyword>Transurethral Resection of Prostate</keyword>
  <keyword>TURP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperplasia</mesh_term>
    <mesh_term>Prostatic Hyperplasia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

